NEW

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

Enexor Ventilator Granted FDA Emergency Use Authorization

X-VENT

Enexor Health Systems announced that the U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization for the immediate delivery and use of a new ventilator, the X-VENT. Enexor will start delivering ventilators to hospitals within a few days.

Guided by the medical team of physicians and respiratory therapists, led by Dr. Bill Walsh of Vanderbilt University’s Monroe Carrol Jr. Children’s Hospital, a pioneer in ventilation technology and one of the design team members of the original oscillating ventilator, the X-VENT was designed to deliver the critical modes of ventilations required for COVID patients.

“The X-VENT is a sophisticated, complex, state-of the-art ventilator capable of providing multiple modes of mechanical ventilation. The engineers did an amazing job keeping it simple, easy to use and inexpensive. It is exactly what the physicians of the world need to support their patients through acute respiratory failure.” states Walsh.

The X-VENT is one of the very few FDA EUA approved ventilators that does not use a bag valve mask (BVM) resuscitator (often referred to colloquially by the proprietary name “Ambu-bag”). The X-VENT utilizes a piston driven air system controlled by a Schneider Electric industrial-grade programmable logic computer (PLC). The system is designed for many years of use, and is self-calibrating, so it can easily be stored. The X-VENT is priced significantly below the cost of a traditional ventilator to encourage world-wide use to impact more lives.

Enexor has leveraged its extensive engineering design, manufacturing, and operational capabilities to quickly design, test and manufacture the unique ventilator.

“Enexor was created to help solve major world problems. In responding to COVID and future pandemics, we stayed true to our mission by putting together an incredible team of medical professionals, engineers and manufacturing specialists with the ultimate mission of designing and manufacturing a durable, reliable, easy to maintain, and affordable ventilator that can be deployed at any hospital in the world to help save lives. The team delivered with the X-VENT,” Enexor Founder and CEO Jestings states.

Enexor has already begun manufacturing ventilators. With the FDA approval, Enexor will ramp up manufacturing to meet the critical needs in the U.S. and internationally.

For more information, visit EnexorHealth.com.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X